Quince Therapeutics
在场
Quince Therapeutics 是一家在股票代码 CRTX (US) 下上市的公司。
高管
查看带有其 17 名主要高管的组织结构图
Quince Therapeutics 搜索最多的简介
- Dirk Thye, Chief Executive Officer and Director
- Rajiv Patni, Director
- David Lamond, Chairman of the Board
创建提醒
跟踪 Quince Therapeutics 的高管变动
健康
Quince Therapeutics 拥有 1,966 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Nestlé Health Science (瑞士)。
Popular M&A news in 健康
- Radon Medical Imaging 已收购 Alpha Imaging (公布2024十一月20号).
- TowerBrook Capital Partners 已收购 R1 RCM (公布2024十一月19号).
- Kewaunee Scientific 已收购 Nu Aire (公布2024十一月6号).
健康 行业的其他推荐联系人
消息
Quince Therapeutics 的最新新闻稿
- Quince Therapeutics Presents Safety Data from Prior Phase 3 ATTeST Clinical Trial at 53rd Child Neurology Society Annual Meeting | Quince Therapeutics
- Quince Therapeutics Presents Data from Prior Phase 3 ATTeST Clinical Trial at 2024 International Congress for Ataxia Research | Quince Therapeutics
- Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results | Quince Therapeutics
- Quince Therapeutics to Participate at Upcoming Investor Conferences | Quince Therapeutics
- Quince Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference | Quince Therapeutics
- News Releases | Quince Therapeutics
- News Releases | Quince Therapeutics
- Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results | Quince Therapeutics
- Quince Therapeutics Announces The Lancet Neurology Publication of Phase 3 ATTeST Clinical Trial Data Evaluating EryDex for the Treatment of Ataxia-Telangiectasia (A-T) | Quince Therapeutics
- News Releases | Quince Therapeutics
- View more press releases Close
通过电子邮件
